Four-year effects of exercise on fatigue and physical activity in patients with cancer

Autor: Lenja Witlox, Anouk E. Hiensch, Miranda J. Velthuis, Charlotte N. Steins Bisschop, Maartje Los, Frans L. G. Erdkamp, Haiko J. Bloemendal, Marlies Verhaar, Daan ten Bokkel Huinink, Elsken van der Wall, Petra H. M. Peeters, Anne M. May

Publikováno v: BMC Medicine, Vol 16, Iss 1, Pp 1-9 (2018)

Abstract Background In the earlier randomized controlled Physical Activity during Cancer Treatment (PACT) study, we found beneficial effects of an 18-week supervised exercise program on fatigue in patients with newly diagnosed breast or colon cancer

Externí odkaz: https://doaj.org/article/aa4f15db4abc44ea875e738b8c37b5ea

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry

Autor: Marissa Meegdes, Khava I. E. Ibragimova, Dorien J. A. Lobbezoo, Ingeborg J. H. Vriens, Loes F. S. Kooreman, Frans L. G. Erdkamp, M. Wouter Dercksen, Birgit E. P. J. Vriens, Kirsten N. A. Aaldering, Manon J. A. E. Pepels, Linda M. H. van de Winkel, Jolien Tol, Joan B. Heijns, Agnes J. van de Wouw, Natascha A. J. B. Peters, Ananda Hochstenbach-Waelen, Marjolein L. Smidt, Sandra M. E. Geurts, Vivianne C. G. Tjan-Heijnen

Publikováno v: Breast Cancer Research and Treatment, 192(2), 331-342. Springer, Cham

Purpose The hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) are the main parameters in guiding systemic treatment choices in breast cancer, but can change during the disease course. This study aims to evaluate the biopsy rat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15a5e909880f3c106d7fac4396b47579
https://doi.org/10.1007/s10549-021-06472-5

Transanal total mesorectal excision and low anterior resection syndrome

Autor: Mathijs P. Hendriks, J M van Dodewaard-de Jong, J W T Dekker, J.A.G. van der Heijden, Bastiaan R. Klarenbeek, A J G Maaskant-Braat, D J A Sonneveld, T van Voorthuizen, Hein B.A.C. Stockmann, L B J Valkenburg-van Iersel, I.H.J.T. de Hingh, F W H Kloppenberg, G R Vink, Seyed M. Qaderi, F H Beverdam, K Talsma, A H W Schiphorst, J F J Vogelaar, Frans L. G. Erdkamp, H W M U van Grevenstein, W J Vles, Marco B. Polee, Jan B.M.J. Jansen, H H Helgason, P P L O Coene, Geerard L. Beets, E J Th Belt, A U G van Lent, Jan N. M. IJzermans, D D E Zimmerman, M L R Tjin-A-Ton, A J ten Tije, M Berbée, Leonie J. M. Mekenkamp, M P S Sie, Annebeth W. Haringhuizen, Koen C.M.J. Peeters, Maartje Los, A M T van der Velden, N A J B Peters, J W B de Groot, Martijn R. Meijerink, A Schouten van der Velden, A I de Vos, J.H.W. de Wilt, Lieke H.J. Simkens, E G G Verdaasdonk, José A. E. Custers, Peter Nieboer, Rob H.A. Verhoeven, M Vermaas, F Terheggen, P Quarles van Ufford-Mannesse, R Blankenburgh, R Hoekstra, R W M Schrauwen, Dirkje W. Sommeijer, R C Rietbroek, H van Cruijsen, L E A Spierings

Publikováno v: British journal of surgery, 108(8), 991-997. John Wiley and Sons Ltd
British Journal of Surgery, 108(8), 991-997. Wiley
PLCRC group 2021, ' Transanal total mesorectal excision and low anterior resection syndrome ', British Journal of Surgery, vol. 108, no. 8, pp. 991-997 . https://doi.org/10.1093/bjs/znab056
British Journal of Surgery, 108, 8, pp. 991-997
British Journal of Surgery, 108, 991-997
British Journal of Surgery, 108(8), 991-997. John Wiley and Sons Ltd

Background Bowel dysfunction after rectal cancer surgery is common, with some experiencing low anterior resection syndrome (LARS) is common after rectal cancer surgery. This study examined if transanal total mesorectal excision (TaTME) has a similar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1fcf9a92def7659b2c98d0089aa720
http://www.scopus.com/inward/record.url?scp=85116172373&partnerID=8YFLogxK

Abstract P1-19-34: The role of hormone receptor (HR) status on initial treatment choices and outcomes for human epidermal growth factor receptor (HER)-2 positive advanced breast cancer: A study of the southeast Netherlands advanced breast cancer (SONABRE) registry

Autor: Sandra M. E. Geurts, Marien O den Boer, Khava I.E. Ibragimova, Maaike de Boer, Frans L. G. Erdkamp, Birgit Epj Vriens, Vivianne C. G. Tjan-Heijnen, M. Wouter Dercksen, Manon J. Pepels, Nathalie J. A. Teeuwen

Publikováno v: Cancer Research. 80:P1-19

Background Previously, we reported that patients with HR+/HER2+ advanced breast cancer diagnosed in 2007-2009 had a better overall survival (OS) than patients with HR-/HER2+ advanced breast cancer (SONABRE Registry, Lobbezoo et al. BCRT 2013). This d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d47a1234dd53235804586280b9f76a84
https://doi.org/10.1158/1538-7445.sabcs19-p1-19-34

The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE Registry

Autor: Marissa, Meegdes, Sandra M E, Geurts, Frans L G, Erdkamp, Marcus Wouter, Dercksen, Birgit E P J, Vriens, Kirsten N A, Aaldering, Manon J A E, Pepels, Linda M H, van de Winkel, Nathalie J A, Teeuwen, Maaike, de Boer, Vivianne C G, Tjan-Heijnen

Publikováno v: International journal of cancer. 150(1)

In August 2017, cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy have been reimbursed in the Netherlands for patients with hormone receptor positive (HR+), HER2 negative (HER2-) advanced breast cancer (ABC). This study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f901f174bde16a07955291e70ce75b93
https://pubmed.ncbi.nlm.nih.gov/34460112